Chugai Pharmaceutical's operating profit FY 2013-2022

Published by
Catharina Klein,
Jun 6, 2024
The Japanese company Chugai Pharmaceutical Co., Ltd reported an operating profit of approximately 452.7 billion Japanese yen in fiscal year 2022, its highest profits of the past decade. The company is expecting a further growth of the operating profit from royalty income for the internally developed product "Hemlibra".

Operating profit of Chugai Pharmaceutical Co., Ltd from fiscal year 2013 to 2022 (in billion Japanese yen)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2023

Region

Japan

Survey time period

fiscal years 2013 to 2022; the fiscal year in Japan starts on April 1st and ends on March 31st the following year

Supplementary notes

100 Japanese yen equal 0.69 U.S. dollars or 0.64 euros as of July 2023.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in China "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in China

Key Figures

7

Drug evaluation and approval

8

Sales channels

7

Pharmaceutical enterprises

7

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.